Class action alleges Oura ring's sleep staging is little better than chance
A proposed class action claims Oura's smart ring cannot accurately determine sleep stages because it lacks neurological sensors. The plaintiff argues the company markets AI-based guesses as reliable science, citing a study showing only 53% accuracy. Oura has defended its technology.
The lawsuit centers on the physiological gap between peripheral biometrics and brain activity. While Oura’s ring tracks heart rate, temperature, and respiration, the plaintiff argues these cannot reliably map to REM, deep, or light sleep stages without electroencephalogram (EEG) data. The cited Nature study’s 53% accuracy figure—barely above random guessing—forms the core evidence, though Oura points to peer-reviewed research supporting its methodology. The case also raises broader questions about how wearables translate raw sensor data into health claims, potentially affecting marketing practices across the industry if courts demand stricter validation standards.
This case could reshape consumer trust in sleep-tracking wearables, which millions rely on for health decisions. If the claim gains traction, buyers may demand clearer disclosure of algorithmic limitations, and manufacturers might face pressure to substantiate accuracy claims with clinical-grade evidence. However, the outcome is uncertain; courts may distinguish between wellness tools and medical devices. The broader impact could be heightened scrutiny of AI-driven health inferences, potentially slowing innovation or prompting more rigorous testing—benefiting informed consumers but raising costs for companies.